Procoralan

Nchi: Umoja wa Ulaya

Lugha: Kiingereza

Chanzo: EMA (European Medicines Agency)

Nunua Sasa

Taarifa za kipeperushi Taarifa za kipeperushi (PIL)
12-10-2021
Tabia za bidhaa Tabia za bidhaa (SPC)
12-10-2021

Viambatanisho vya kazi:

ivabradine hydrochloride

Inapatikana kutoka:

Les Laboratoires Servier

ATC kanuni:

C01EB17

INN (Jina la Kimataifa):

ivabradine

Kundi la matibabu:

Cardiac therapy

Eneo la matibabu:

Angina Pectoris; Heart Failure

Matibabu dalili:

Symptomatic treatment of chronic stable angina pectoris Ivabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate ≥ 70 bpm. Ivabradine is indicated :in adults unable to tolerate or with a contraindication to the use of beta-blockersor in combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose.Treatment of chronic heart failure Ivabradine is indicated in chronic heart failure NYHA II to IV class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.

Bidhaa muhtasari:

Revision: 22

Idhini hali ya:

Authorised

Idhini ya tarehe:

2005-10-25

Taarifa za kipeperushi

                                28
B. PACKAGE LEAFLET
29
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
PROCORALAN 5
MG FILM-COATED TABLETS
PROCORALAN 7.5
MG FILM-COATED TABLETS
ivabradine
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Procoralan is and what it is used for
2.
What you need to know before you take Procoralan
3.
How to take Procoralan
4.
Possible side effects
5
How to store Procoralan
6.
Contents of the pack and other information
1.
WHAT PROCORALAN IS AND WHAT IT IS USED FOR
Procoralan (ivabradine) is a heart medicine used to treat:
-
Symptomatic stable angina pectoris (which causes chest pain) in adult
patients whose heart rate is
over or equal to 70 beats per minute. It is used in adult patients who
do not tolerate or cannot take
heart medicines called beta-blockers. It is also used in combination
with beta-blockers in adult
patients whose condition is not fully controlled with a beta-blocker.
-
Chronic heart failure in adult patients whose heart rate is over or
equal to 75 beats per minute. It is
used in combination with standard therapy, including beta-blocker
therapy or when beta-blockers
are contraindicated or not tolerated.
About stable angina pectoris (usually referred to as “angina”):
Stable angina is a heart disease which happens when the heart does not
receive enough oxygen. The
most common symptom of angina is chest pain or discomfort.
About chronic heart failure :
Chronic heart failure is a heart disease which happens when your heart
cannot pump enough blood to
the rest of your body. The most c
                                
                                Soma hati kamili
                                
                            

Tabia za bidhaa

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Procoralan 5 mg film-coated tablets
Procoralan 7.5 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_ _
Procoralan 5 mg film-coated tablets
Each film-coated tablet contains 5 mg ivabradine (as hydrochloride).
_Excipient with known effect: _
Each film-coated tablet contains 63.91 mg lactose monohydrate.
Procoralan 7.5 mg film-coated tablets
Each film-coated tablet contains 7.5 mg ivabradine (as hydrochloride).
_Excipient with known effect: _
Each film-coated tablet contains 61.215 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet.
Procoralan 5 mg film-coated tablets
Salmon-coloured, oblong, film-coated tablet scored on both sides,
engraved with “5” on one face
and
on the other face.
The tablet can be divided into equal doses.
Procoralan 7.5 mg film-coated tablets
Salmon-coloured, triangular, film-coated tablet engraved with
“7.5” on one face and
on the other
face.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Symptomatic treatment of chronic stable angina pectoris
Ivabradine is indicated for the symptomatic treatment of chronic
stable angina pectoris in coronary
artery disease adults with normal sinus rhythm and heart rate ≥ 70
bpm. Ivabradine is indicated:
-
in adults unable to tolerate or with a contraindication to the use of
beta-blockers
-
or in combination with beta-blockers in patients inadequately
controlled with an optimal beta-
blocker dose.
3
Treatment of chronic heart failure
Ivabradine is indicated in chronic heart failure NYHA II to IV class
with systolic dysfunction, in adult
patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in
combination with standard therapy
including beta-blocker therapy or when beta-blocker therapy is
contraindicated or not tolerated (see
section 5.1).
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Symptomatic treatment of chronic stable angina pectoris _
It is recommended that the deci
                                
                                Soma hati kamili
                                
                            

Nyaraka katika lugha zingine

Taarifa za kipeperushi Taarifa za kipeperushi Kibulgaria 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kibulgaria 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kibulgaria 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kihispania 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kihispania 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kihispania 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kicheki 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kicheki 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kicheki 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kidenmaki 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kidenmaki 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kidenmaki 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kijerumani 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kijerumani 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kijerumani 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kiestonia 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kiestonia 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiestonia 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kigiriki 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kigiriki 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kigiriki 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kifaransa 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kifaransa 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kifaransa 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kiitaliano 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kiitaliano 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiitaliano 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kilatvia 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kilatvia 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kilatvia 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kilithuania 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kilithuania 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kilithuania 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kihungari 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kihungari 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kihungari 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kimalta 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kimalta 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kimalta 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kiholanzi 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kiholanzi 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiholanzi 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kipolandi 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kipolandi 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kipolandi 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kireno 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kireno 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kireno 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kiromania 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kiromania 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiromania 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kislovakia 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kislovakia 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kislovakia 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kislovenia 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kislovenia 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kislovenia 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kifinlandi 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kifinlandi 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kifinlandi 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kiswidi 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kiswidi 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiswidi 26-02-2019
Taarifa za kipeperushi Taarifa za kipeperushi Kinorwe 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kinorwe 12-10-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kiaisilandi 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kiaisilandi 12-10-2021
Taarifa za kipeperushi Taarifa za kipeperushi Kroeshia 12-10-2021
Tabia za bidhaa Tabia za bidhaa Kroeshia 12-10-2021
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kroeshia 26-02-2019

Tafuta arifu zinazohusiana na bidhaa hii

Tazama historia ya hati